Monotherapy versus combination therapy used as first-line therapy for primary hypertension

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 1, 2013, Pages

  Garjón, Javier ^a   Azparren, Ana ^a   Elizondo, José J ^b   Gaminde, Idoia ^b   Ariz, M José ^c   Erviti, Juan ^a   Saiz, Luis Carlos ^a  

^a Navarre Regional Health Service   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Navarre Health Service   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANEURYSM RUPTURE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMBINATION DRUG THERAPY; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUDDEN DEATH; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 85041727448     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010316     Document Type: Article

References (10)

1. Canadian Hypertension Education Program. CHEP recommendations for management of hypertension. Markham (ON): Hypertension Canada, 2012:39 p.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007;28(12):1462-536. [PUBMED: 17562668]
3. U.S. Food, Drug Administration. FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna). http://www.fda.gov/drugs/drugsafety/ucm300889.htm (accessed 18 August 2012) 20 April 2012.
4. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. Journal of Clinical Hypertension (Greenwich, Conn.) 2011;13(3):146-54. [PUBMED: 21366845]
5. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
6. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. ICH Harmonised Tripartite Guideline. London (UK): European Medicines Agency;1995 Jun. CPMP/ICH/377/95.
7. National Clinical Guideline Centre. Hypertension: the clinical management of primary hypertension in adults. London (UK): National Clinical Guideline Centre, 2011 Aug.
8. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11, 000 participants from 42 trials. The American Journal of Medicine 2009;122(3):290-300. [PUBMED: 19272490]
9. Wright James M, Musini Vijaya M. First-line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]
10. Yusuf Salim, Teo Koon K, Pogue Janice, Dyal Leanne, Copland Ingrid, Schumacher Helmut, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England Journal of Medicine 2008;358(15):1547-59.